Verrica Pharmaceuticals Inc. Accumulated Other Comprehensive Income
Verrica Pharmaceuticals Inc. (VRCA) had Accumulated Other Comprehensive Income of $0 as of 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2023-03-06
- 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2022-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$29.00K.
- 2022-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$64.00K.
- 2022-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$62.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-06 |
| 2022-09-30 | -$29.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$64.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$62.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$29.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | -$2.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$1.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $3.00K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $1.00K 10-K · filed 2022-03-02 |
| 2020-09-30 | $6.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $32.00K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $20.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $20.00K 10-K · filed 2021-03-17 |
| 2019-09-30 | $27.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $38.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $11.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$17.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | -$7.00K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |